Therapeutic Implication of MiRNAs As an Active Regulatory Player in the Management of Pain: A Review
Overview
Overview
Authors
Affiliations
Affiliations
Soon will be listed here.
Abstract
Chronic pain is frequently associated with neuropathy, inflammation, or the malfunctioning of nerves. Chronic pain is associated with a significant burden of morbidity due to opioid use, associated with addiction and tolerance, and disability. MicroRNAs (miRs) are emerging therapeutic targets to treat chronic pain through the regulation of genes associated with inflammation, neuronal excitability, survival, or de-differentiation. In this review, we discuss the possible involvement of miRs in pain-related molecular pathways. miRs are known to regulate high-conviction pain genes, supporting their potential as therapeutic targets.
References
1.
Tsuda M, Koga K, Chen T, Zhuo M
. Neuronal and microglial mechanisms for neuropathic pain in the spinal dorsal horn and anterior cingulate cortex. J Neurochem. 2017; 141(4):486-498.
DOI: 10.1111/jnc.14001.
View
2.
Gupta A, Jakobsson J
. Acetaminophen, nonsteroidal anti-inflammatory drugs, and cyclooxygenase-2 selective inhibitors: an update. Plast Reconstr Surg. 2014; 134(4 Suppl 2):24S-31S.
DOI: 10.1097/PRS.0000000000000672.
View
3.
Kynast K, Russe O, Geisslinger G, Niederberger E
. Novel findings in pain processing pathways: implications for miRNAs as future therapeutic targets. Expert Rev Neurother. 2013; 13(5):515-25.
DOI: 10.1586/ern.13.34.
View
4.
Mercadante S
. Opioid Analgesics Adverse Effects: The Other Side of the Coin. Curr Pharm Des. 2019; 25(30):3197-3202.
DOI: 10.2174/1381612825666190717152226.
View
5.
Lutz B, Bekker A, Tao Y
. Noncoding RNAs: new players in chronic pain. Anesthesiology. 2014; 121(2):409-17.
PMC: 4110167.
DOI: 10.1097/ALN.0000000000000265.
View